73 related articles for article (PubMed ID: 11439901)
1. [Effect and action mechanism of short-term administration of clarithromycin for airway hypersecretion].
Tagaya E; Tamaoki A; Kondo M; Nakada J; Nagai A
Jpn J Antibiot; 2001 Feb; 54 Suppl A():33-5. PubMed ID: 11439901
[No Abstract] [Full Text] [Related]
2. [Effect of macrolides on rat models of airway hypersecretion].
Majima Y; Ishikawa M; Sugawara Y; Nakase K
Jpn J Antibiot; 2001 Feb; 54 Suppl A():36-8. PubMed ID: 11439902
[No Abstract] [Full Text] [Related]
3. Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion.
Tagaya E; Tamaoki J; Kondo M; Nagai A
Chest; 2002 Jul; 122(1):213-8. PubMed ID: 12114361
[TBL] [Abstract][Full Text] [Related]
4. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
Nalepa P; Dobryniewska M; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyclooxygenase inhibitor on excessive sputum.
Inoue H; Aizawa H; Koto H; Miyagawa Y; Ikeda T; Shigematsu N
Fukuoka Igaku Zasshi; 1991 Apr; 82(4):177-80. PubMed ID: 1905674
[TBL] [Abstract][Full Text] [Related]
6. Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections.
Tamaoki J; Takeyama K; Tagaya E; Konno K
Antimicrob Agents Chemother; 1995 Aug; 39(8):1688-90. PubMed ID: 7486901
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism and management of airway hypersecretion in obstructive lung disease].
Tamaoki J
Nihon Rinsho; 1999 Sep; 57(9):2056-61. PubMed ID: 10497406
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Notario G; Spiller J; Palmer R; Busman T
Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
[TBL] [Abstract][Full Text] [Related]
9. Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin.
Vagliasindi M
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):245-9. PubMed ID: 9208340
[TBL] [Abstract][Full Text] [Related]
10. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis.
Tamaoki J; Chiyotani A; Kobayashi K; Sakai N; Kanemura T; Takizawa T
Am Rev Respir Dis; 1992 Mar; 145(3):548-52. PubMed ID: 1546834
[TBL] [Abstract][Full Text] [Related]
11. Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis.
Lin HC; Cheng HF; Wang CH; Liu CY; Yu CT; Kuo HP
Am J Respir Crit Care Med; 1997 Jun; 155(6):2024-9. PubMed ID: 9196111
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled study comparing the effect of azithromycin with clarithromycin on oropharyngeal and bowel microflora in volunteers.
Matute AJ; Schurink CA; Krijnen RM; Florijn A; Rozenberg-Arska M; Hoepelman IM
Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):427-31. PubMed ID: 12111597
[TBL] [Abstract][Full Text] [Related]
13. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
[TBL] [Abstract][Full Text] [Related]
14. Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational study.
Coeman M; van Durme Y; Bauters F; Deschepper E; Demedts I; Smeets P; Joos G; Brusselle G
Ther Adv Respir Dis; 2011 Dec; 5(6):377-86. PubMed ID: 21890536
[TBL] [Abstract][Full Text] [Related]
15. [Influence of long-term macrolide therapy for chronic inflammation of respiratory tract on concurrent helicobacter pylori infection of stomach].
Hino M; Ono Y; Kokubo Y; Soma T; Tanaka Y; Uehara T; Narato R; Yoshioka Y; Kudo S
Jpn J Antibiot; 2003 Apr; 56 Suppl A():47-50. PubMed ID: 14679746
[No Abstract] [Full Text] [Related]
16. Clarithromycin targets neutrophilic airway inflammation in refractory asthma.
Simpson JL; Powell H; Boyle MJ; Scott RJ; Gibson PG
Am J Respir Crit Care Med; 2008 Jan; 177(2):148-55. PubMed ID: 17947611
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.
Serisier DJ; Martin ML; McGuckin MA; Lourie R; Chen AC; Brain B; Biga S; Schlebusch S; Dash P; Bowler SD
JAMA; 2013 Mar; 309(12):1260-7. PubMed ID: 23532242
[TBL] [Abstract][Full Text] [Related]
18. Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis.
Langan C; Clecner B; Cazzola CM; Brambilla C; Holmes CY; Staley H
Int J Clin Pract; 1998; 52(5):289-97. PubMed ID: 9796558
[TBL] [Abstract][Full Text] [Related]
19. Effects of clarithromycin on oral mucositis in bone marrow transplant recipients.
Yuen KY; Woo PC; Tai JW; Lie AK; Luk J; Liang R
Haematologica; 2001 May; 86(5):554-5. PubMed ID: 11410428
[No Abstract] [Full Text] [Related]
20. The concentrations of clarithromycin and its 14-hydroxy metabolite in sputum of patients with bronchiectasis following single dose oral administration.
Tsang KW; Roberts P; Read RC; Kees F; Wilson R; Cole PJ
J Antimicrob Chemother; 1994 Feb; 33(2):289-97. PubMed ID: 8182010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
